The sales revenue of the BioTechUSA company group increased by 40 percent last year
The BioTechUSA company group closed the year 2022 with a record financial result, its sales revenue increased by 41 percent and reached HUF 80.4 billion, its earnings before interest, taxes and depreciation (EBITDA) increased from HUF 9.2 billion to HUF 11.5 billion.
The Hungarian family-owned group of companies expanded its portfolio with 300 new products, opened 17 new stores and launched the largest investment in its history in 2022, which will continue this year – explained Bálint Lévai, CEO and co-owner of BioTechUSA Kft., at the press conference presenting the company’s annual results.
About 80 percent of the total sales revenue of one of the largest food supplement and specialty food manufacturing and distribution groups in Europe last year came from exports, and the international store network produced a 216 percent increase in turnover.
Related news
The implementation of gap-filling healthcare innovations has been given the green light
The BioTechUSA Health Awards were presented for the first time…
Read more >The BioTechUSA group of companies welcomes applications from domestic healthcare institutions
Three categories, audience prize, HUF 18 million in total prize…
Read more >Sales of cereals increased the most
Among the 24 commodity groups of agricultural and food industry…
Read more >Related news
KSH: retail turnover in November exceeded the same period of the previous year by 4.1 percent and the previous month by 0.6 percent
In November 2024, the volume of retail trade turnover increased…
Read more >NGM: Public confidence is apparently starting to return
The government is working to improve the economy so that…
Read more >Fidelity Outlook 2025: The US is ready for reflation
The Republicans’ landslide victory in the November election has significantly…
Read more >